2025年6月,MDPI期刊 Pharmacoepidemiology 正式被ESCI (Web of Science) 与Scopus (Elsevier) 收录。在此,衷心感谢作者对期刊的支持,感谢主编、编委、客座编辑与审稿专家的重要贡献和读者的持续关注。
截至目前,MDPI已出版期刊474个,其中220个期刊已被ESCI收录,343个期刊已被Scopus收录。 (查看MDPI ESCI详细名单,请点击:https://www.mdpi.com/about/journals/esci)。
期刊简介
Pharmacoepidemiology (ISSN 2813-0618) 创刊于2022年,是一个国际性开放获取期刊。期刊内容涵盖药物流行病学,临床药理学与流行病学的各个方面。
期刊历程
期刊正式上线,作为季刊发行
被ESCI收录
被Scopus收录
发文类型
原创型研究论文、综述、简报等。
期刊主编
![]() |
Dr. Carlotta Franchi Laboratory of Pharmacoepidemiology and Human Nutrition, Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy |
期刊编委
![]() |
Prof. Dr. Li-Chia Chen Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, University of Manchester, Manchester, UK |
![]() |
Dr. Hao Hu Institute of Chinese Medical Sciences, University of Macau, Macao, China |
![]() |
Dr. Francisco T.T. Lai Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong |
投稿优势
除ESCI及Scopus之外,Pharmacoepidemiology 目前还被DOAJ、CNKI等数据库收录。
Time to First Decision | 21.6 Days |
Acceptance to Publication | 3.2 Days |
读者可以免费阅读期刊文章。
点击链接,订阅期刊最新资讯:https://www.mdpi.com/journal/pharmacoepidemiology/toc-alert。
高引文章推荐
1. Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States
丁丙诺啡-纳洛酮对有医疗保险的阿片类药物使用障碍患者过量及死亡风险的干预效果评估
Tianyu Sun et al.
点击链接,阅读英文原文:https://www.mdpi.com/2813-0618/1/3/10。
Sun, T.; Katenka, N.; Kogut, S.; Bratberg, J.; Rich, J.; Buchanan, A. Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States. Pharmacoepidemiology 2022, 1, 101-112.
2. Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for Helicobacter pylori Therapy
抗菌药物管理危机:克拉霉素在幽门螺杆菌治疗中的滥用问题
David Y. Graham
点击链接,阅读英文原文:https://www.mdpi.com/2813-0618/3/1/6。
Graham, D.Y. Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for Helicobacter pylori Therapy. Pharmacoepidemiology 2024, 3, 82-93.
3. Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease
他汀类药物之外:新型降脂药物降低动脉粥样硬化性心血管疾病风险的研究
Teimur Kayani et al.
点击链接,阅读英文原文:https://www.mdpi.com/2813-0618/3/1/9。
Kayani, T.; Ahmad, B.; Chang, R.S.; Qian, F.; Sahinoz, M.; Rehan, M.W.; Giaimo, A.; Spatz, E.S.; Hu, J.-R. Beyond Statins: Novel Lipid-Lowering Agents for Reducing Risk of Atherosclerotic Cardiovascular Disease. Pharmacoepidemiology 2024, 3, 117-168.
4. Adverse Drug Reactions in Multimorbid Older People Exposed to Polypharmacy: Epidemiology and Prevention
多重用药下共病老年患者药物不良反应的流行病学与预防研究
Siobhán McGettigan, Denis Curtin and Denis O' Mahony
点击链接,阅读英文原文:https://www.mdpi.com/2813-0618/3/2/13。
McGettigan, S.; Curtin, D.; O' Mahony, D. Adverse Drug Reactions in Multimorbid Older People Exposed to Polypharmacy: Epidemiology and Prevention. Pharmacoepidemiology 2024, 3, 208-222.
特刊推荐
1. Women's Special Issue Series: Pharmacoepidemiology
Edited by Dr. Carlotta Franchi, Prof. Dr. Li-Chia Chen and Dr. Carlotta Lunghi
Submission Deadline: 31 October 2025
点击链接,了解更多信息:https://www.mdpi.com/journal/pharmacoepidemiology/special_issues/62CULMB5J3。
2. Recent Advances in the Pharmacoepidemiology of Antirheumatic Medication
Edited by Dr. Roberta Foti, Dr. Beatrice Maranini and Dr. Veronica Venturelli
Submission Deadline: 30 September 2025
点击链接,了解更多信息:https://www.mdpi.com/journal/pharmacoepidemiology/special_issues/X2YPD19CDR。
3. Exploring Herbal Medicine: Applying Epidemiology Principles
Edited by Dr. Christos Kontogiorgis
Submission Deadline: 31 October 2025
点击链接,了解更多信息:https://www.mdpi.com/journal/pharmacoepidemiology/special_issues/17483YI17F。
作者指南
如您对投稿有任何疑问,欢迎阅读作者指南,或联系 Pharmacoepidemiology 期刊编辑部 (pharmacoepidemiology@mdpi.com)。
点击下方链接,阅读作者指南。
https://www.mdpi.com/journal/pharmacoepidemiology/instructions
会议预告
中国药理学会第十七次学术大会
时间:2025年07月22日 - 2025年07月26日
地点:河北 雄安
点击下方链接,了解会议详情。